Canagliflozin, An SGLT2 Inhibitor, Prevents Lung Remodeling in Chronic Left Ventricular Failure

被引：0
|
作者：
Kanuparthy, M. [1 ]
Harris, D. D. [1 ]
Hamze, J. [1 ]
Broadwin, M. [1 ]
Stone, C. [1 ]
Banerjee, D. [1 ]
Sellke, F. W. [1 ]
机构：
[1] Brown Univ, Providence, RI USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A7134
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Carcinogenicity in rats of the SGLT2 inhibitor canagliflozin
    De Jonghe, Sandra
    Proctor, Jim
    Vinken, Petra
    Feyen, Bianca
    Wynant, Inneke
    Marien, Dirk
    Geys, Helena
    Mamidi, Rao N. V. S.
    Johnson, Mark D.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2014, 224 : 1 - 12
  • [2] Invokana (Canagliflozin), an SGLT2 inhibitor, launched in the UK
    不详
    DIABETES OBESITY & METABOLISM, 2014, 16 (05): : 480 - 480
  • [3] Fanconi syndrome associated with SGLT2 inhibitor, canagliflozin
    Esprit, Don H.
    Koratala, Abhilash
    NEPHROLOGY, 2018, 23 (05) : 493 - 493
  • [4] Canagliflozin: A Novel SGLT2 Inhibitor for Type 2 Diabetes Mellitus
    Kaushal, Shaveta
    Singh, Harmanjit
    Thangaraju, Pugazhenthan
    Singh, Jasbir
    NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES, 2014, 6 (03) : 107 - 113
  • [5] Canagliflozin, a Novel SGLT2 Inhibitor for Treatment of Type 2 Diabetes
    Nigro, Stefanie C.
    Riche, Daniel M.
    Pheng, Michelle
    Baker, William L.
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (10) : 1301 - 1311
  • [6] The SGLT2 Inhibitor Canagliflozin Prevents Increased Lipid Oxidation in the Heart following High-Fat Feeding
    Flores, Itzel
    Shannon, Chris
    Fourcaudot, Marcel
    Bakewell, Terry
    Norton, Luke
    DIABETES, 2019, 68
  • [7] The SGLT2 Inhibitor Canagliflozin Reduces Atherosclerosis by Enhancing Macrophage Autophagy
    Chen, Hongping
    Teng, Da
    Xu, Bowen
    Wang, Chunxiao
    Wang, Hua
    Jia, Wenjuan
    Gong, Lei
    Dong, Haibin
    Zhong, Lin
    Yang, Jun
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2023, 16 (05) : 999 - 1009
  • [8] The SGLT2 Inhibitor Canagliflozin Reduces Atherosclerosis by Enhancing Macrophage Autophagy
    Hongping Chen
    Da Teng
    Bowen Xu
    Chunxiao Wang
    Hua Wang
    Wenjuan Jia
    Lei Gong
    Haibin Dong
    Lin Zhong
    Jun Yang
    Journal of Cardiovascular Translational Research, 2023, 16 : 999 - 1009
  • [9] SGLT2 Inhibitors A Review of Canagliflozin
    Willson, Megan N.
    White, John R., Jr.
    US PHARMACIST, 2013, 38 (10) : HS13 - HS20
  • [10] Mode of SGLT inhibition by an SGLT2 inhibitor, canagliflozin and implication in renal and small intestinal effects
    Kuriyama, Chiaki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S22 - S22
12345